GlassScriptPhysician profile
Rafael L Prieto
NPI 1699710426
$3,916.24
in general payments reported to CMS, 2019-2025
23 companies · $45.74 in 2025
The $45.74 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,936 · 2020: $747 · 2021: $888 · 2022: $299 · 2025: $45.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $45.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $45.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,264.46 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $671.84 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $501.58 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $318.42 | 2019-2022 | |
| Boston Scientific Corporation | $181.46 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Pfizer INC. | $177.29 | 2019-2021 | |
| Zyla Life Sciences, INC. | $170.15 | 2019-2020 | |
| Abbott Laboratories | $133.65 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $104.03 | 2019-2021 | |
| Daiichi Sankyo INC. | $78.57 | 2019 | |
| Virtus Pharmaceuticals LLC | $59.58 | 2020 | |
| Sanofi-Aventis U.S. LLC | $40.23 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $33.15 | 2019 | |
| Shionogi INC | $26.83 | 2019 | |
| Allergan, INC. | $24.08 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $21.04 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.37 | 2019 | |
| Grt US Holding, INC. | $19.00 | 2021 | |
| Mdd US Operations, LLC | $18.30 | 2020 | |
| Medtronic USA, INC. | $15.15 | 2019 | |
| Horizon Therapeutics Plc | $14.70 | 2019 | |
| Redhill Biopharma INC. | $12.53 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Prieto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.